Yamamoto N | Thoracic Oncology Division National Cancer Center Hospital National Cancer Center

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)
Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
日本人におけるヒトSLC29A1の新規遺伝子多型の同定
Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days
Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
Three novel single nucleotide polymorphisms in UGT1A10
Bodyweight change during the first 5 days of chemotherapy as an indicator of cisplatin renal toxicity
Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
INHIBITORY EFFECTS OF REPEATED INTRAVENOUS INJECTIONS OF DEXAMETHASONE ON PULMONARY TOXICITY OF A NEW MITOMYCIN C ANALOGUE, KW-2149, IN A NOVEL RAT MODEL
Inhibitory effects of dexamethasone on pulmonary toxicity of a new mitomycin C analogue KW-2149 in a novel rat model.
Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
Phase I and pharmacokinetic study of vorinostat (suberoylanilide hydroxamic acid) in Japanese patients with solid tumors
Phase I study of TLR9 agonist PF-3512676 in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer
Innovator and generic cisplatin formulations : Comparison of renal toxicity

もっと見る

スポンサーリンク